Ingrid U. Scott
Scott, Ingrid U.
VIAF ID: 19163659 (Personal)
Permalink: http://viaf.org/viaf/19163659
Preferred Forms
- 100 0 _ ‡a Ingrid U. Scott
- 200 _ | ‡a Scott ‡b Ingrid U.
-
-
- 100 1 _ ‡a Scott, Ingrid U.
- 100 1 _ ‡a Scott, Ingrid U.
- 100 1 _ ‡a Scott, Ingrid U.
Works
Title | Sources |
---|---|
Diabetes and ocular disease : past, present, and future therapies | |
In vitro fluoroquinolone resistance in staphylococcal endophthalmitis isolates | |
Intravitreal injection of autologous bone marrow-derived mononuclear cells for hereditary retinal dystrophy: a phase I trial. | |
Intravitreal injection of ranibizumab during cataract surgery in patients with diabetic macular edema. | |
Intravitreal triamcinolone versus bevacizumab for treatment of refractory diabetic macular oedema (IBEME study). | |
Is the use of topical antibiotics for intravitreal injections the standard of care or are we better off without antibiotics? | |
Laser scanning imaging for macular disease: a report by the American Academy of Ophthalmology | |
Late endophthalmitis associated with glaucoma drainage implants | |
Legacy of the endophthalmitis vitrectomy study | |
Long-term anatomic and visual acuity outcomes after initial anatomic success with macular hole surgery | |
Long-term follow-up of unoperated macular holes | |
LONG-TERM PHYSICAL STABILITY, STERILITY, AND ANTI-VEGF BIOACTIVITY OF REPACKAGED BEVACIZUMAB IN 2-ML GLASS VIALS | |
Low vision services: a practical guide for the clinician | |
Macular retinoschisis associated with pathologic myopia | |
Mitomycin C versus 5-fluorouracil as an adjunctive treatment for trabeculectomy: a meta-analysis of randomized clinical trials | |
Month 12 Outcomes After Treatment Change at Month 6 Among Poor Responders to Aflibercept or Bevacizumab in Eyes With Macular Edema Secondary to Central or Hemiretinal Vein Occlusion: A Secondary Analysis of the SCORE2 Study | |
Multiple Bilateral Retinal Breaks as a Long-Term Complication of Retinopathy of Prematurity Treated with Intravitreal Bevacizumab | |
Necrotizing herpetic retinopathy associated with Ramsay Hunt syndrome. | |
Neuroprotective effects of oral lamotrigine administration on rabbit retinas after pars plana vitrectomy and silicone oil injection. | |
Now that we have the results of the subretinal surgery trials, how do we manage the patient? | |
Occult chorioretinal anastomosis in age-related macular degeneration: a prospective study by optical coherence tomography | |
OCT findings in macular hole formation in eyes with complete vitreofoveal separation | |
Ocular findings in a patient with Castleman's disease before and after treatment with immunosuppression and plasmapheresis | |
Ocular nutritional supplements: are their ingredients and manufacturers' claims evidence-based? | |
Open globe injuries with positive intraocular cultures: factors influencing final visual acuity outcomes | |
Ophthalmic resident education on preventable surgical errors | |
Ophthalmology residency program leadership expectations of resident competency in retinal procedures and resident experience with retinal procedures | |
Optical coherence tomography findings in patients with late solar retinopathy | |
Optical coherence tomography measurements and analysis methods in optical coherence tomography studies of diabetic macular edema | |
Outcomes of complex retinal detachment repair using 1000- vs 5000-centistoke silicone oil. | |
Outcomes of surgery for retinal detachment associated with proliferative vitreoretinopathy using perfluoro-n-octane: a multicenter study | |
Pain during pars plana vitrectomy following sub-Tenon versus peribulbar anesthesia: A randomized trial | |
Panretinal photocoagulation versus PRP plus intravitreal bevacizumab for high-risk proliferative diabetic retinopathy (IBeHi study). | |
Pars plana lensectomy, pars plana vitrectomy, and silicone oil tamponade as initial management of cataract and combined traction/rhegmatogenous retinal detachment involving the macula associated with severe proliferative diabetic retinopathy | |
Patient perceptions of discomfort and changes in vision and functional status associated with intravitreal triamcinolone injection | |
Pharmacokinetic and toxicity investigations of a new intraocular lens with a dexamethasone drug delivery system: a pilot study | |
Pharmacotherapy for diabetic retinopathy | |
Polypoidal choroidal vasculopathy: angiographic characterization of the network vascular elements and a new treatment paradigm. | |
Potential impact of seatbelt use on the spectrum of ocular injuries and visual acuity outcomes after motor vehicle accidents with airbag deployment | |
Povidone-iodine for endophthalmitis prophylaxis | |
Practice Patterns Among Eye Care Providers at US Teaching Hospitals With Regard to Assessing and Educating Patients About Smoking | |
Practice patterns of cataract surgeons at academic medical centers for the management of inadequate capsule support for intracapsular or sulcus intraocular lens placement during cataract surgery. | |
Prevalence and predictors of ocular complications associated with cataract surgery in United States veterans | |
Primary intraocular posttransplantation lymphoproliferative disorder | |
Pseudohypopyon after intravitreal triamcinolone acetonide injection for cystoid macular edema | |
Quality of life of low-vision patients and the impact of low-vision services | |
A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with standard care to treat vision loss associated with macular Edema secondary to branch retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal [...] | |
Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema | |
Ranibizumab for retinal neovascularization | |
Reducing the Disclosure Effect in the Vitreoretinal Fellowship Match | |
Reducing the risk of endophthalmitis following intravitreal injections | |
Refractive surgical practices in persons with human immunodeficiency virus positivity or acquired immune deficiency syndrome | |
Regional anesthesia with monitored anesthesia care for surgical repair of selected open globe injuries | |
Repeatability and comparability of keratometry measurements obtained with swept-source optical coherence and combined dual-Scheimpflug Placido-disc-based tomography | |
Reply | |
Resident Wellness in US Ophthalmic Graduate Medical Education: The Resident Perspective | |
Resolution of choroidal folds and improvement in visual acuity after orbital decompression for graves orbitopathy. | |
Resolution of retinal pigment epithelial detachment associated with exudative age-related macular degeneration following intravitreal ranibizumab therapy | |
Retinal detachment in eyes undergoing pars plana vitrectomy for removal of retained lens fragments | |
Retinal detachment in patients with a preexisting glaucoma drainage device: anatomic, visual acuity, and intraocular pressure outcomes | |
Retinal vascular occlusions | |
Rhegmatogenous retinal detachment in retinoblastoma patients undergoing chemoreduction and cryotherapy | |
Routine neuroimaging in retinoblastoma for the detection of intracranial tumors. | |
Ruthenium-106 brachytherapy and intravitreal bevacizumab for retinal capillary hemangioma | |
SAFETY AND FEASIBILITY OF A NOVEL 25-GAUGE BIODEGRADABLE IMPLANT OF DEXAMETHASONE FOR TREATMENT OF MACULAR EDEMA ASSOCIATED WITH RETINAL VEIN OCCLUSION: A PHASE I CLINICAL TRIAL. | |
Scleral buckle for progressive symptomatic retinal detachment complicating retinoschisis versus primary rhegmatogenous retinal detachment | |
A semi-automated machine-learning based workflow for ellipsoid zone analysis in eyes with macular edema: SCORE2 pilot study | |
Vitreoretinal disease : diagnosis, management, and clinical pearls |